{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T10:14:13Z","timestamp":1789035253956,"version":"build-2803163510"},"reference-count":40,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxics"],"abstract":"<jats:p>California\u2019s Proposition 65 requires warning labels for chemicals associated with carcinogenicity or reproductive toxicity, affecting global cosmetic and fragrance formulations. While safrole has an established safe harbor level (No Significant Risk Level, NSRL) of 3 \u00b5g\/day, its structural analogues, estragole and methyleugenol, lack specific safe harbor thresholds. To address this data gap using non-animal methodologies, this study evaluated a Next-Generation Risk Assessment (NGRA) workflow combining read-across and in silico modeling. Structural, physicochemical, and skin-permeation profiling supported category homogeneity (Tanimoto Tc \u2265 0.82 and comparable log Kp values) in accordance with OECD and ECHA guidelines. Multi-platform QSAR consensus (ToxTree, Danish QSAR, and VEGA QSAR) indicated that while parent phenylpropenes lack direct bacterial mutagenicity, they share a hepatic bioactivation pathway leading to mammalian clastogenicity and carcinogenicity predictions. Molecular docking with human Cytochrome P450 1A2 (CYP1A2; PDB: 2H14) identified safrole as the category\u2019s conservative toxicological benchmark, exhibiting the highest binding affinity (\u22128.026 kcal\/mol) and closest proximity to the catalytic HEME iron. Consequently, applying safrole\u2019s 3 \u00b5g\/day NSRL to estragole and methyleugenol provides a quantitative threshold to evaluate consumer exposure in cosmetic products, ensuring public health protection and regulatory compliance.<\/jats:p>","DOI":"10.3390\/toxics14090782","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T15:09:28Z","timestamp":1788534568000},"page":"782","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Establishing Proposition 65 Safe Harbor Levels for Estragole and Methyleugenol in Cosmetics: A Mechanistic Read-Across from Safrole"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1786-4756","authenticated-orcid":false,"given":"Gabriela","family":"Corr\u00eaa","sequence":"first","affiliation":[{"name":"Safety Assessment Management, Grupo Botic\u00e1rio, R. Alfredo Pinto, 2258, Parque da Fonte, S\u00e3o Jos\u00e9 dos Pinhais 83050-320, PR, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tugst\u00eanio","family":"Souza","sequence":"additional","affiliation":[{"name":"Safety Assessment Management, Grupo Botic\u00e1rio, R. Alfredo Pinto, 2258, Parque da Fonte, S\u00e3o Jos\u00e9 dos Pinhais 83050-320, PR, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"},{"role":"software","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1913-9450","authenticated-orcid":false,"given":"Eduarda","family":"Conde","sequence":"additional","affiliation":[{"name":"Safety Assessment Management, Grupo Botic\u00e1rio, R. Alfredo Pinto, 2258, Parque da Fonte, S\u00e3o Jos\u00e9 dos Pinhais 83050-320, PR, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9ia","family":"Oliveira","sequence":"additional","affiliation":[{"name":"Safety Assessment Management, Grupo Botic\u00e1rio, R. Alfredo Pinto, 2258, Parque da Fonte, S\u00e3o Jos\u00e9 dos Pinhais 83050-320, PR, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6271-2407","authenticated-orcid":false,"given":"Nat\u00e1lia","family":"Vita","sequence":"additional","affiliation":[{"name":"Safety Assessment Management, Grupo Botic\u00e1rio, R. Alfredo Pinto, 2258, Parque da Fonte, S\u00e3o Jos\u00e9 dos Pinhais 83050-320, PR, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Motter Catarino","sequence":"additional","affiliation":[{"name":"Safety Assessment Management, Grupo Botic\u00e1rio, R. Alfredo Pinto, 2258, Parque da Fonte, S\u00e3o Jos\u00e9 dos Pinhais 83050-320, PR, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"}]},{"given":"Andrezza","family":"Canavez","sequence":"additional","affiliation":[{"name":"Safety Assessment Management, Grupo Botic\u00e1rio, R. Alfredo Pinto, 2258, Parque da Fonte, S\u00e3o Jos\u00e9 dos Pinhais 83050-320, PR, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"13583","DOI":"10.1021\/acs.est.9b03794","article-title":"Assessing Human Exposure to Chemicals in Materials, Products and Articles: The International Risk Management Landscape for Phthalates","volume":"53","author":"Eichler","year":"2019","journal-title":"Environ. Sci. Technol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1080\/10408444.2021.2003295","article-title":"Assessing Chemical Carcinogenicity: Hazard Identification, Classification, and Risk Assessment. Insight from a Toxicology Forum State-of-the-Science Workshop","volume":"51","author":"Felter","year":"2021","journal-title":"Crit. Rev. Toxicol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.1021\/acs.est.4c07495","article-title":"How a Right-to-Know Law Shifts Industry Away from Chemicals of Concern: The Case of California\u2019s Proposition 65","volume":"59","author":"Ohayon","year":"2025","journal-title":"Environ. Sci. Technol."},{"key":"ref_4","unstructured":"OEHHA (Office of Environmental Health Hazard Assessment) (2026, July 09). What We Do, Available online: https:\/\/oehha.ca.gov\/about\/what-we-do."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e70035","DOI":"10.1111\/joca.70035","article-title":"YOU HAVE BEEN WARNED: The Effect of California\u2019s Proposition 65 Warning on Consumer Perceptions and Evaluations","volume":"59","author":"Drury","year":"2025","journal-title":"J. Consum. Aff."},{"key":"ref_6","unstructured":"OEHHA (Office of Environmental Health Hazard Assessment) (2026, August 28). The Proposition 65 List, Available online: https:\/\/oehha.ca.gov\/proposition-65\/proposition-65-list."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"7454","DOI":"10.1021\/acs.est.2c07247","article-title":"Identifying Toxic Consumer Products: A Novel Data Set Reveals Air Emissions of Potent Carcinogens, Reproductive Toxicants, and Developmental Toxicants","volume":"57","author":"Knox","year":"2023","journal-title":"Environ. Sci. Technol."},{"key":"ref_8","unstructured":"OEHHA (Office of Environmental Health Hazard Assessment) (2026, July 09). Proposition 65 No Significant Risk Levels (NSRLs) and Maximum Allowable Dose Levels (MADLs), Available online: https:\/\/oehha.ca.gov\/proposition-65\/general-info\/proposition-65-no-significant-risk-levels-nsrls-and-maximum-allowable-dose-levels-madls."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1289\/ehp.81429","article-title":"Dose-Response Analysis in Animal Studies: Prediction of Human Responses","volume":"42","author":"Alarie","year":"1981","journal-title":"Environ. Health Perspect."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S2213-8587(20)30128-5","article-title":"Endocrine-Disrupting Chemicals: Economic, Regulatory, and Policy Implications","volume":"8","author":"Kassotis","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_11","unstructured":"SCCS (Scientific Committee on Consumer Safety) (2023). SCCS Notes of Guidance for the Testing of Cosmetic Ingredients and Their Safety Evaluation 12th Revision, European Commission. SCCS\/1647\/22."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s002040050502","article-title":"Computer-Based Bioassay for Evaluation of Sensory Irritation of Airborne Chemicals and Its Limit of Detection","volume":"72","author":"Alarie","year":"1998","journal-title":"Arch. Toxicol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Eisenreich, A., G\u00f6tz, M.E., Sachse, B., Monien, B.H., Herrmann, K., and Sch\u00e4fer, B. (2021). Alkenylbenzenes in Foods: Aspects Impeding the Evaluation of Adverse Health Effects. Foods, 10.","DOI":"10.3390\/foods10092139"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1007\/s00204-020-02733-2","article-title":"Mode of Action-Based Risk Assessment of Genotoxic Carcinogens","volume":"94","author":"Hartwig","year":"2020","journal-title":"Arch. Toxicol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.taap.2010.01.016","article-title":"A Physiologically Based Biodynamic (PBBD) Model for Estragole DNA Binding in Rat Liver Based on in Vitro Kinetic Data and Estragole DNA Adduct Formation in Primary Hepatocytes","volume":"245","author":"Paini","year":"2010","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0009-2797(97)00133-6","article-title":"Sulfotransferase-Mediated Activation of Mutagens Studied Using Heterologous Expression Systems","volume":"109","author":"Glatt","year":"1998","journal-title":"Chem. Biol. Interact."},{"key":"ref_17","unstructured":"ICCS (International Collaboration on Cosmetics Safety) (2026). Best Practice Guidance Document: Read-Across, International Collaboration on Cosmetics Safety."},{"key":"ref_18","unstructured":"ECHA (European Chemicals Agency) (2017). Read-Across Assessment Framework (RAAF), European Chemicals Agency."},{"key":"ref_19","unstructured":"OECD (Organisation for Economic Co-operation and Development) (2025). Guidance on Grouping of Chemicals, OECD Publishing. [3rd ed.]."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.drudis.2006.10.005","article-title":"Similarity-Based Virtual Screening Using 2D Fingerprints","volume":"11","author":"Willett","year":"2006","journal-title":"Drug Discov. Today"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"D1373","DOI":"10.1093\/nar\/gkac956","article-title":"PubChem 2023 Update","volume":"51","author":"Kim","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S1574-1400(08)00012-1","article-title":"Chapter 12\u2014PubChem: Integrated Platform of Small Molecules and Biological Activities","volume":"Volume 4","author":"Wheeler","year":"2008","journal-title":"Annual Reports in Computational Chemistry"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1021\/jm020155c","article-title":"Do Structurally Similar Molecules Have Similar Biological Activity?","volume":"45","author":"Martin","year":"2002","journal-title":"J. Med. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: A Free Web Tool to Evaluate Pharmacokinetics, Drug-Likeness and Medicinal Chemistry Friendliness of Small Molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_25","unstructured":"ECHA (2017). Chapter R.7a: Endpoint Specific Guidance. Guidance on Information Requirements and Chemical Safety Assessment, European Chemicals Agency."},{"key":"ref_26","unstructured":"OECD (2007). Guidance Document on the Validation of (Quantitative) Structure-Activity Relationship [(Q)SAR] Models (No. 69), OECD Publishing."},{"key":"ref_27","unstructured":"Benigni, R., Bossa, C., Jeliazkova, N., Netzeva, T., and Worth, A. (2008). The Benigni\/Bossa Rulebase for Mutagenicity and Carcinogenicity\u2014A Module of Toxtree, Office for Official Publications of the European Communities. JRC Publications Repository."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.tiv.2010.08.019","article-title":"Physiologically Based Biokinetic Model of Bioactivation and Detoxification of the Alkenylbenzene Methyleugenol in Rat","volume":"25","author":"Spenkelink","year":"2011","journal-title":"Toxicol. Vitr."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1021\/tx700012d","article-title":"Human Cytochrome P450 Enzyme Specificity for the Bioactivation of Estragole and Related Alkenylbenzenes","volume":"20","author":"Jeurissen","year":"2007","journal-title":"Chem. Res. Toxicol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: Improving the Speed and Accuracy of Docking with a New Scoring Function, Efficient Optimization, and Multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4310\/CIS.241021221101","article-title":"Docking Strategies for Predicting Protein-Ligand Interactions and Their Application to Structure-Based Drug Design","volume":"24","author":"Ma","year":"2024","journal-title":"Commun. Inf. Syst."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1517\/17425255.4.5.513","article-title":"Computational Prediction of Drug Binding and Rationalisation of Selectivity towards Cytochromes P450","volume":"4","author":"Stjernschantz","year":"2008","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/978-1-4939-8630-9_5","article-title":"Protein-Ligand Docking in Drug Design: Performance Assessment and Binding-Pose Selection","volume":"1824","author":"Ballante","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.dmpk.2019.11.006","article-title":"Computational Prediction of Cytochrome P450 Inhibition and Induction","volume":"35","author":"Kato","year":"2020","journal-title":"Drug Metab. Pharmacokinet."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.yrtph.2019.03.018","article-title":"The Implementation of RAAF in the OECD QSAR Toolbox","volume":"105","author":"Kuseva","year":"2019","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.yrtph.2015.05.016","article-title":"A Strategy for Structuring and Reporting a Read-across Prediction of Toxicity","volume":"72","author":"Schultz","year":"2015","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Sansen, S., Yano, J.K., Reynald, R.L., Schoch, G.S., Stout, C.D., and Johnson, E.F. (2006). Crystal Structure of Human Microsomal P450 1A2 in Complex with \u03b1-Naphthoflavone, RCSB PDB.","DOI":"10.2210\/pdb2hi4\/pdb"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"14348","DOI":"10.1074\/jbc.M611692200","article-title":"Adaptations for the Oxidation of Polycyclic Aromatic Hydrocarbons Exhibited by the Structure of Human P450 1A2","volume":"282","author":"Sansen","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_39","unstructured":"National Research Council (US) Committee on Comparative Toxicity of Naturally Occurring Carcinogens (1996). Carcinogens and Anticarcinogens in the Human Diet: A Comparison of Naturally Occurring and Synthetic Substances, National Academies Press. The National Academies Collection: Reports funded by National Institutes of Health."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1021\/cr030049y","article-title":"Structure-Activity Relationship Studies of Chemical Mutagens and Carcinogens: Mechanistic Investigations and Prediction Approaches","volume":"105","author":"Benigni","year":"2005","journal-title":"Chem. Rev."}],"container-title":["Toxics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2305-6304\/14\/9\/782\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T09:51:07Z","timestamp":1789033867000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2305-6304\/14\/9\/782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":40,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["toxics14090782"],"URL":"https:\/\/doi.org\/10.3390\/toxics14090782","relation":{},"ISSN":["2305-6304"],"issn-type":[{"value":"2305-6304","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,4]]}}}